4th Quarter - Report

VIATRIS INC. for VIATRIS INC

Firm
Client
Income
—
Expenses
$650,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Financial Institutions/Investments/Securities FIN

Policy related to corporate governance

LobbyistCovered position, as disclosed
DAVID MARIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

Corporate Tax Policy

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Veterans VET

VA Access to affordable medicines

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

H.R. 3 - Lower Drug Costs Now Act; H.R. 2846 - Ensuring Access to Lower-Cost Medicines for Seniors Act; H.R. 5376 - the Inflation Reduction Act of 2022; S. 4348 - the Food and Drug Administration Safety and Landmark Advancements Act of 2022; Biosimilar interchangeability ; Part D Formulary Design and Generic Drug Tiering; H.R. 7667 - the Food and Drug Amendments of 2022; H.R. 8239 - Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2023, and for other purposes; S. 4338 - the Increasing Transparency in Generic Drug Applications Act S. 4351 - the Enhanced Access to Affordable Medicines Act H.R. 7559 - the Prescription Information Modernization Act of 2022; H.R. 2617 - Consolidated Appropriations Act of 2023

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 4338 (117th), H.R. 3 (117th), H.R. 7559 (117th), H.R. 5376 (117th), H.R. 2617 (117th), H.R. 7667 (117th), S. 4351 (117th), H.R. 8239 (117th), H.R. 2846 (117th), S. 4348 (117th)

Copyright/Patent/Trademark CPT

Issues related Inter Partes Review (IPR) process for biosimilars and generic drugs Patent Settlements

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Trade issues related to generic medicines Pharmaceutical supply chain

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.